{
    "uniprot_canonical_ac": "A0A0G2JVF0-1",
    "uniprot_id": [
        {
            "id": "A0A0G2JVF0_RAT",
            "url": "https://www.uniprot.org/uniprot/A0A0G2JVF0_RAT",
            "type": "external"
        }
    ],
    "mass": 107336.0,
    "length": 965,
    "protein_name": "Rho GTPase activating protein 4",
    "gene_name": "Arhgap4",
    "organism": "Rat",
    "refseq_name": "rho GTPase-activating protein 4",
    "refseq_ac": [
        {
            "id": "NP_653341",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_653341",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "Arhgap4",
    "gene_names_refseq": "Arhgap4",
    "protein_names_uniprotkb": "Rho GTPase activating protein 4",
    "protein_names_refseq": "rho GTPase-activating protein 4",
    "tax_id": 10116,
    "disease": "",
    "pathway": " (rno:246249);  (R-RNO-8980692);  (R-RNO-9013148);  (R-RNO-9013149)",
    "pathway_count": 4,
    "publication_count": 3,
    "publication_id_list": "12414125;17804252;22673903",
    "function": "ARHGAP4 occured in the hippocampus, ventral region of the brainstem and striatum, and in cerebellar granule cells. Subcellularly, ARHGAP4 localized to the Golgi complex and could redistribute to the microtubules, for example during mitosis., [RefSeq, PubMed]; These observations suggest that ARHGAP4 can act as a potent inhibitor of cell and axon motility when it is localized to the leading edge of motile cells and axons., [RefSeq, PubMed]",
    "predicted_glycosites": 0,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 0,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 0,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 0,
    "glyco_site_count": 0,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0005096 GTPase activator activity",
    "go_cellular_component": "GO:0005737 cytoplasm;GO:0005874 microtubule;GO:0030426 growth cone;GO:0005654 nucleoplasm;GO:0005829 cytosol",
    "go_biological_process": "GO:0010764 negative regulation of fibroblast migration;GO:0007165 signal transduction;GO:0007399 nervous system development;GO:0030336 negative regulation of cell migration;GO:0035023 regulation of Rho protein signal transduction",
    "synthesized_glycan_count": 0,
    "record_id": "A0A0G2JVF0-1",
    "record_type": "protein",
    "filter_code": "0000000.0000101.010000.0000000000001000.00000.000"
}